{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:44:19Z","timestamp":1761561859329},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/adt.0000000000000047","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T16:15:39Z","timestamp":1397664939000},"page":"211-219","source":"Crossref","is-referenced-by-count":6,"title":["Recruitment Techniques for Alcohol Pharmacotherapy Clinical Trials"],"prefix":"10.1097","volume":"14","author":[{"given":"D. Andrew","family":"Tompkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.","family":"Sides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric C.","family":"Strain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2174\/138161211796150765","article-title":". Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review.","volume":"17","author":"Edwards","year":"2011","journal-title":"Curr Pharm Des"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/00952999209026069","article-title":"Implementation issues and techniques in randomized trials of outpatient psychosocial treatments for drug abusers: recruitment of subjects.","volume":"18","author":"Ashery","year":"1992","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1369-1600.2012.00454.x","article-title":". Medications development to treat alcohol dependence: a vision for the next decade.","volume":"17","author":"Litten","year":"2012","journal-title":"Addict Biol"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.addbeh.2003.08.010","article-title":". Who gets in Recruitment and screening processes of outpatient substance abuse trials.","volume":"29","author":"Sayre","year":"2004","journal-title":"Addict Behav"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1465-3362.2008.00022.x","article-title":". Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence.","volume":"28","author":"Morley","year":"2009","journal-title":"Drug Alcohol Rev"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"72","DOI":"10.15288\/jsas.2005.s15.72","article-title":". Recruiting and retaining participants in a combined behavioral and pharmacological clinical trial.","volume":"15","author":"Zweben","year":"2005","journal-title":"J Stud Alcohol Suppl"},{"key":"R8-7-20210126","doi-asserted-by":"crossref","first-page":"62","DOI":"10.15288\/jsas.1994.s12.62","article-title":". Issues in the development of subject recruitment strategies and eligibility criteria in multisite trials of matching.","volume":"12","author":"Zweben","year":"1994","journal-title":"J Stud Alcohol Suppl"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":". A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence.","volume":"7","author":"Litten","year":"2013","journal-title":"J Addict Med"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1530-0277.2011.01716.x","article-title":". A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.","volume":"36","author":"Fertig","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1360-0443.1997.tb03370.x","article-title":"The efficacy of disulfiram: a review of outcome studies.","volume":"92","author":"Hughes","year":"1997","journal-title":"Addiction"},{"key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1530-0277.2001.tb02356.x","article-title":"Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.","volume":"25","author":"Kranzler","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1176\/appi.ajp.157.4.588","article-title":"Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies.","volume":"157","author":"Humphreys","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R15-7-20210126","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/00952990.2011.596973","article-title":". Conducting research with racialethnic minorities: methodological lessons from the NIDA Clinical Trials Network.","volume":"37","author":"Burlew","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R16-7-20210126","first-page":"26","article-title":"How advertising works: what do we really know J Market.","volume":"63","author":"Vakratsas","year":"1999","journal-title":""},{"key":"R17-7-20210126","first-page":"14","article-title":"What does effective frequency mean in 1997 J Advert Res.","volume":"37","author":"Jones","year":"1997","journal-title":""},{"key":"R19-7-20210126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.drugalcdep.2012.10.003","article-title":". Utilization of communication technology by patients enrolled in substance abuse treatment.","volume":"129","author":"McClure","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"R20-7-20210126","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ntr\/ntr051","article-title":". Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers.","volume":"13","author":"Ryan","year":"2011","journal-title":"Nicotine Tob Res"}],"container-title":["Addictive Disorders & Their Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADT.0000000000000047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:09:01Z","timestamp":1620943741000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00132576-201512000-00007"}},"subtitle":["A Cost-benefit Analysis"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/adt.0000000000000047","relation":{},"ISSN":["1531-5754"],"issn-type":[{"value":"1531-5754","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}